Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies.

Authors:
Krzemień P; Kasperczyk S; Banach M; Kasperczyk A; Dobrakowski M and 16 more

Journal:
Arch Med Sci

Publication Year: 2021

DOI:
10.5114/aoms/139313

PMCID:
PMC10507751

PMID:
37732061

Journal Information

Journal Title: Arch Med Sci

Detailed journal information not available.

Publication Details

Subject Category: Medicine, General & Internal

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest JJJ and MB have received an unrestricted educational grant from Valeant, and have served as consultants or speakers for Valeant. PK is employed by Euroimmun Polska Sp. z o.o., (Wroclaw, Poland), whose autoantibody reagents were used in the study. PEP owns four shares in AstraZeneca PLC and has received honoraria and/or travel reimbursement for events sponsored by AKCEA, Amgen, AMRYT, Link Medical, Mylan, Napp, Sanofi. All other authors have no conflict of interest concerning the results of this analysis."

Evidence found in paper:

"Research funding: The present study was an initiative of the Polish Lipid Association (PoLA) and the College of Family Physicians in Poland (CFPiP). The present study was funded by an unrestricted educational grant from Valeant (Warsaw, Poland). Valeant had no role in study design, data analysis, data interpretation, or writing of the report. The present study was also supported by the Silesian Analytical Laboratories (SLA), CHDE, BIO-RAD and Euroimmun."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025